These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 4372825)

  • 81. Individual levels of plasma histidine-rich glycoprotein (HRG) during the normal menstrual cycle and in women on oral contraceptives low in oestrogen.
    Jespersen J; Kluft C
    Scand J Clin Lab Invest; 1982 Nov; 42(7):563-6. PubMed ID: 6818678
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [Monitoring of plasma renin activity, renin substrate and aldosterone concentrations during treatment with hormonal contraceptives (proceedings)].
    Kaulhausen H; Heidrich A; Oehm W; Fritzsche G; Breuer H
    Arch Gynakol; 1977 Jul; 224(1-4):430-1. PubMed ID: 579892
    [No Abstract]   [Full Text] [Related]  

  • 83. [Influence of progestins on adverse effects of oral contraceptives].
    Wynn V
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [A new estrogen variant in the oral contraceptive Non-Ovlon].
    Sarembe B
    Dtsch Gesundheitsw; 1973; 28(5):223-7. PubMed ID: 4579102
    [No Abstract]   [Full Text] [Related]  

  • 85. [Clinical trials of an association of norgestrel and ethinyl estradiol commercialized under the name of Stediril].
    Gaudefroy M; Corette L; Coliche D
    Bull Fed Soc Gynecol Obstet Lang Fr; 1971; 23(4):434. PubMed ID: 5153231
    [No Abstract]   [Full Text] [Related]  

  • 86. A possible mechanism for hypertension induced by oral contraceptives. Diminished feedback suppression of renin release.
    Saruta T; Saade GA; Kaplan NM
    Arch Intern Med; 1970 Oct; 126(4):621-6. PubMed ID: 4319180
    [No Abstract]   [Full Text] [Related]  

  • 87. Progestational agents and blood coagulation. VI. Relationship of ABO blood types to changes induced by oral contraceptives.
    Lillie MA; Mink IB
    Am J Obstet Gynecol; 1974 Jun; 119(3):406-10. PubMed ID: 4827381
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Comparative studies of the ethynyl estrogens used in oral contraceptives: effects with and without progestational agents on plasma cortisol and cortisol binding in humans, baboons, and beagles.
    Goldzieher JW; Chenault CB; de la Pena A; Dozier TS; Kraemer DC
    Fertil Steril; 1977 Nov; 28(11):1182-90. PubMed ID: 411689
    [No Abstract]   [Full Text] [Related]  

  • 89. Oestrogen, proestogen and liver function tests.
    Eisalo A; Heino A; Räsänen V
    Acta Obstet Gynecol Scand; 1968; 47(1):58-65. PubMed ID: 5669834
    [No Abstract]   [Full Text] [Related]  

  • 90. Effect of ethinyl oestradiol and megestrol acetate on carbohydrate metabolism in rabbits.
    Gaitonde BB; Kulkarni HJ
    Indian J Med Res; 1977 Aug; 66(2):223-35. PubMed ID: 924594
    [No Abstract]   [Full Text] [Related]  

  • 91. [Clinical trial of oral contraceptive agent, Combiquens].
    Welti H
    Ther Umsch; 1973 Jul; 30(7):543-9. PubMed ID: 4578456
    [No Abstract]   [Full Text] [Related]  

  • 92. [Studies on the mechanism of action of me-quingestanol on fertility in the rabbit (author's transl)].
    Wei YM
    Zhonghua Fu Chan Ke Za Zhi; 1979 Apr; 14(2):73-8. PubMed ID: 263036
    [No Abstract]   [Full Text] [Related]  

  • 93. Enhanced platelet aggregation by oral contraceptives: effect of PG synthetase inhibitors.
    Sudhir S; Gupta LC; Singh J; Garg KN
    Indian J Physiol Pharmacol; 1982; 26(3):231-4. PubMed ID: 6816736
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Thiamine status and oral contraceptives.
    Briggs MH; Briggs M
    Contraception; 1975 Feb; 11(2):151-4. PubMed ID: 1112084
    [No Abstract]   [Full Text] [Related]  

  • 95. Effects of ethinylestradiol on the renin-angiotensin-aldosterone-system and on plasma transcortin in women and men.
    Oelkers W; Blümel A; Schöneshöfer M; Schwartz U; Hammerstein J
    J Clin Endocrinol Metab; 1976 Nov; 43(5):1036-40. PubMed ID: 993310
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Oral contraceptives and high blood pressure: a review.
    Fregly MJ; Fregly MS
    J Fla Med Assoc; 1977 Feb; 64(2):84-91. PubMed ID: 839193
    [No Abstract]   [Full Text] [Related]  

  • 97. [Kinetics of renin reaction in rat plasma (author's transl)].
    Campillo JE; Quesada T; Sánchez-Cantalejo E; Osorio J; Osorio C
    Rev Esp Fisiol; 1976 Mar; 32(1):33-6. PubMed ID: 1257568
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Complications of systemic contraceptive agents: hypertension.
    Wolfsen AR
    West J Med; 1975 Jan; 122(1):38-40. PubMed ID: 1089005
    [No Abstract]   [Full Text] [Related]  

  • 99. Plasma renin concentration: comparison of angiotensinase inhibitors and correlation with plasma renin activity and aldosterone.
    Kodish ME; Katz FH
    J Lab Clin Med; 1974 May; 83(5):705-15. PubMed ID: 4362565
    [No Abstract]   [Full Text] [Related]  

  • 100. Plasma renin activity and aldosterone excretion rate in normal subjects. I. Effect of ethinyl estradiol and medroxyprogesterone acetate.
    Crane MG; Harris JJ
    J Clin Endocrinol Metab; 1969 Apr; 29(4):550-7. PubMed ID: 5779247
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.